Related references
Note: Only part of the references are listed.Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based Chemotherapy
Kathryn J. Ruddy et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2020)
Descriptive epidemiology of cancer in metropolitan France: Incidence, survival and prevalence
Anne Cowppli-Bony et al.
BULLETIN DU CANCER (2019)
Relapse Risk and Loss of Lifetime After Modern Combined Modality Treatment of Young Patients With Hodgkin Lymphoma: A Nordic Lymphoma Epidemiology Group Study
Jorne Lionel Biccler et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Real world data as a key element in precision medicine for lymphoid malignancies: potentials and pitfalls
Tarec C. El-Galaly et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
A French Multicentric Prospective Cohort of 6000 Patients with Integrative Epidemiological, Clinical, Biological and Treatment Data to Improve Knowledge on Outcome of Lymphoma Patients: Pilot Phase Results of the Real World Data in Lymphoma and Survival in Adults (REALYSA) Study
Herve Ghesquieres et al.
BLOOD (2019)
Association of Occupational Pesticide Exposure With Immunochemotherapy Response and Survival Among Patients With Diffuse Large B-Cell Lymphoma
Sylvain Lamure et al.
JAMA NETWORK OPEN (2019)
Survival benefit of mantle cell lymphoma patients enrolled in clinical trials; a joint study from the LYSA group and French cancer registries
Alix Augustin et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2018)
International development of four EORTC disease-specific quality of life questionnaires for patients with Hodgkin lymphoma, high- and low-grade non-Hodgkin lymphoma and chronic lymphocytic leukaemia
Lonneke van de Poll-Franse et al.
QUALITY OF LIFE RESEARCH (2018)
How to investigate and adjust for selection bias in cohort studies
Ellen A. Nohr et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2018)
Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN)
Alexandra Smith et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Quality of life at diagnosis predicts overall survival in patients with aggressive lymphoma
Carrie A. Thompson et al.
HEMATOLOGICAL ONCOLOGY (2018)
Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort
Alexandra Smith et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
Reflection on modern methods: selection bias-a review of recent developments
Claire Infante-Rivard et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2018)
Diagnosis-to-Treatment Interval Is an Important Clinical Factor in Newly Diagnosed Diffuse Large B-Cell Lymphoma and Has Implication for Bias in Clinical Trials
Matthew J. Maurer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Bjoern Chapuy et al.
NATURE MEDICINE (2018)
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma
R. Schmitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The association of physical activity before and after lymphoma diagnosis with survival outcomes
Priyanka A. Pophali et al.
AMERICAN JOURNAL OF HEMATOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma
Jonathon B. Cohen et al.
BLOOD (2017)
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role?
Sandra Le Guyader-Peyrou et al.
HAEMATOLOGICA (2017)
Factors related to the relative survival of patients with diffuse large B-cell lymphoma in a population-based study in France: does socio-economic status have a role?
Sandra Le Guyader-Peyrou et al.
HAEMATOLOGICA (2017)
Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study
James R. Cerhan et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2017)
Impact of Expert Pathologic Review of Lymphoma Diagnosis: Study of Patients From the French Lymphopath Network
Camille Laurent et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients
Fabrice Denis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making
Marc L. Berger et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
The prognostic value of clonal heterogeneity and quantitative assessment of plasma circulating clonal IG-VDJ sequences at diagnosis in patients with follicular lymphoma
Clementine Sarkozy et al.
ONCOTARGET (2017)
Randomized Trial Comparing a Web-Mediated Follow-up With Routine Surveillance in Lung Cancer Patients
Fabrice Denis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma
Anupama Reddy et al.
CELL (2017)
Early event status informs subsequent outcome in newly diagnosed follicular lymphoma
Matthew J. Maurer et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
No survival benefit associated with routine surveillance imaging for Hodgkin lymphoma in first remission: a Danish-Swedish population-based observational study
Lasse H. Jakobsen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia
Greg Hapgood et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Real-World Evidence - What Is It and What Can It Tell Us?
Rachel E. Sherman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Familial predisposition and genetic risk factors for lymphoma
James R. Cerhan et al.
BLOOD (2015)
Survival variations by country and age for lymphoid and myeloid malignancies in Europe 2000-2007: Results of EUROCARE-5 population-based study
Roberta De Angelis et al.
EUROPEAN JOURNAL OF CANCER (2015)
New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy
Dai Chihara et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2015)
Genome-Wide Association Study of Event-Free Survival in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Herve Ghesquieres et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Socioeconomic disparities in lymphoma
Christopher R. Flowers et al.
BLOOD (2014)
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
C. M. Booth et al.
BRITISH JOURNAL OF CANCER (2014)
Representativeness
Lorenzo Richiardi et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2014)
Utility of Routine Post-Therapy Surveillance Imaging in Diffuse Large B-Cell Lymphoma
Carrie A. Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes
Julia F. Simard et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Why representativeness should be avoided
Kenneth J. Rothman et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)
Screening older cancer patients: first evaluation of the G-8 geriatric screening tool
C. A. Bellera et al.
ANNALS OF ONCOLOGY (2012)
Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: Analysis of a national clinical database
Birgitte Lidegaard Frederiksen et al.
EUROPEAN JOURNAL OF CANCER (2011)
The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research
Alexandra Smith et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Smoking, Alcohol Use, Obesity, and Overall Survival From Non-Hodgkin Lymphoma
Susan M. Geyer et al.
CANCER (2010)
Alcohol consumption and non-Hodgkin lymphoma survival
Xuesong Han et al.
JOURNAL OF CANCER SURVIVORSHIP (2010)
A short generic measure of work stress in the era of globalization: effort-reward imbalance
Johannes Siegrist et al.
INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH (2009)
Survival in non-Hodgkin's lymphoma by histology and family history
Jianguang Ji et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
Survival Patterns Among Lymphoma Patients With a Family History of Lymphoma
Lesley A. Anderson et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Socio-economic deprivation and survival of non-Hodgkin lymphoma in Scotland
Caroline Bray et al.
LEUKEMIA & LYMPHOMA (2008)
The impact of tobacco smoking and alcohol drinking on survival of patients with non-Hodgkin lymphoma
Renato Talamini et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Cigarette smoking and alcohol consumption as determinants of survival in non-Hodgkin's lymphoma: a population-based study
T. Battaglioli et al.
ANNALS OF ONCOLOGY (2006)
Follicular lymphoma international prognostic index
P Solal-Céligny et al.
BLOOD (2004)
A structural approach to selection bias
MA Hernán et al.
EPIDEMIOLOGY (2004)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests
JM Robins et al.
BIOMETRICS (2000)
Share Paper
